Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01085396 · ClinicalTrials.gov registry record

Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin

A clinical trial, sponsored by University of Pittsburgh.

Terminated
Registry status
16
Enrollment target

NCT01085396 is a clinical trial that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 16 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01085396 was terminated before completion, sponsored by University of Pittsburgh.

TERMINATED
Registry status
16 participants
Enrollment target

Study Summary

This study is designed to collect information about melanoma using a research probe, a device placed only on the skin. This study will investigate whether using the probe to examine skin lesions could improve the accuracy of identification pre-cancerous melanoma lesions or to predict the risk melanoma in the skin of subjects. Ultimately, we would see this technique used routinely as a non-invasive device during subjects' skin examination to aid dermatologists to identify pre-cancerous (melanoma) lesions without taking tissue samples of the skin. Alternatively, this technique would, in the future, also be used to screen patients at risk for melanoma.

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2010-03
Est. Completion 2014-10

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT01085396

The ClinicalTrials.gov registry entry for NCT01085396 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01085396 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01085396 about?

NCT01085396 is a clinical study titled "Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin". This study is designed to collect information about melanoma using a research probe, a device placed only on the skin. This study will investigate whether using the probe to examine skin lesions could improve the accuracy of identification pre-cancerous melanoma lesions or to predict the risk melano...

What is the current status of trial NCT01085396?

This trial is currently terminated. The enrollment target is 16 participants. The study started on 2010-03. Estimated completion is 2014-10.

Who is sponsoring clinical trial NCT01085396?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.